Atara Biotherapeutics (ATRA) Receivables (2020 - 2026)
Atara Biotherapeutics (ATRA) reported Receivables of $318,000 for Q2 2026.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics posted Receivables of $1.25 million, down 15.5% from FY2024.
- Receivables has declined for three consecutive years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- By year, Receivables came in at $1.48 million in FY2024 (-95.7%), $34.11 million in FY2023 (-15.2%), $40.22 million in FY2022 and $986,000 in FY2021 (-21.1%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables since Q3 2023.
- Year over year, Receivables gained in two of the last five quarters, with growth averaging 115.2%.
- The high point for year-over-year Receivables in five years was Q3 2024 (growth of 719.0%); the low point was Q4 2024 (a decline of 95.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 318,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 318,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 8.88 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 35.83 Mn |
| Dec 31, 2023 | 34.11 Mn |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 507,000.00 |
| Mar 31, 2023 | 397,000.00 |
| Dec 31, 2022 | 40.22 Mn |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 637,000.00 |
| Mar 31, 2022 | 668,000.00 |
| Dec 31, 2021 | 986,000.00 |
| Mar 31, 2021 | 9.61 Mn |
| Dec 31, 2020 | 1.25 Mn |
API Access
Atara Biotherapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();